The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Why Choose Us?   Results   Search

Previous Investigations Other Litigations Bextra Research Center News & Warnings

About the Bextra Recall

in this section: FDA Press Release | FDA Health Advisory | Pfizer Response | FDA Report Dec '04 | Public Citizen Petition | World's Reaction | Stevens-Johnson Syndrome | FDA Talk Papers | FDA Q&A Dec 04 | Arthritis Society PR | Chelsea Therapeutics | Our Press Release | Letter To Clients

Bookmark This Page Print This Page Email This Page

Letter to our clients about the Bextra recall and Celebrex black box warning

About the Bextra Recall: To our clients, past, present, and future,

New York, NY April 8, 2005 -- The pain relieving drug Bextra, manufactured by Pfizer Pharmaceuticals, was withdrawn from the market on April 7, 2005, after the FDA determined Bextra presented an unacceptably high risk of adverse cardiovascular events and potentially fatal skin reactions such as Stevens Johnson Syndrome. Bextra also failed to demonstrate an advantage over other NSAID drugs available on the market.

Weitz & Luxenberg has already been retained by thousands of individuals who have been similarly injured as a result of Vioxx, another recalled NSAID. In addition, over the past six months our attorneys and support staff have been accepting and investigating individual cases involving injuries caused by Bextra. If you have taken Bextra (20mg or more/day) and have suffered a heart attack, stroke, or other serious cardiovascular problem, or if you have developed a severe skin reaction or Stevens Johnson syndrome, you should contact Weitz & Luxenberg as son as possible to discuss your legal options.

Clients should also be aware that another NSAID, Celebrex (also made by Pfizer) was required to carry the FDA's most serious warning, a black box, on April 7, 2005. The black box warning alerts patients to the increased risk of cardiovascular and gastrointestinal dangers while taking Celebrex. Celebrex has been linked to strokes, heart attacks, and potentially life-threatening GI bleeding. Weitz & Luxenberg is currently investigating injuries caused by Celebrex use (400mg or more daily).

If you are currently taking Bextra or Celebrex, discuss with your doctor about the risks and benefits associated with these drugs. If you have been injured by taking Bextra or Celebrex, fill out our Bextra or Celebrex forms, go to our FREE Bextra and Celebrex case evaluators and get your claim reviewed at no cost to you. You can contact our client relations department directly, and examine Weitz & Luxenberg's extensive Bextra and Celebrex research resources to get more information on these dangerous drugs.

If you've been hurt by Bextra or Celebrex, Weitz & Luxenberg will help you know your rights and get the compensation you deserve.

Sincerely,

Your friends at Weitz & Luxenberg.

If you've been injured by Bextra, Celebrex, or Vioxx contact Weitz & Luxenberg today for a free legal consultation. Fill out this simple form, email us at clientrelations@weitzlux.com or call us at 1(800) 476-6070.


Act now! It is essential that you inquire about your case as soon as possible. Litigation may be the only way to receive the damages to which you may be entitled, such as medical and health care bills, lost or diminished wages, and financial compensation to family in the case of death. Your individual state's law can limit your time to bring a legal claim to protect your rights. You need to have your Bextra claim evaluated immediately!

Weitz & Luxenberg is no longer accepting Bextra cases.


see also:

Public Citizen Petition Bextra Lawyer - Public Citizen Bextra Recall Petition
Bextra Lawyer - Bextra recall petition from Public Citizen to the FDA.

Chelsea Therapeutics Bextra lawyers - Bextra Recall information Chelsea Therapeutics
Chelsea Threapeutics Bextra Recall Press Release

Breaking news Breaking Lawsuit Resource Center: Bextra Breaking News
Bextra (Valdecoxib) Resource Center: Bextra Breaking News

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question

Click here
for a free case review

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims

$25 million jury verdict — brake reliner

$5.8 million settlement — failure to perform timely C-Section

$30 million verdict — 7 former power-plant workers suffering from asbestos-related illnesses

$6 million settlement — pediatric malpractice case

$14 million consolidated verdict — 5 asbestos-related cancer suits: shipyards/powerhouses/construction

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$3.5 million — 2 asbestos exposure cases

$600,000 settlement — motor vehicle negligence resulting in serious injury

$44 million verdict — 5 asbestos cases, including $11.6 million awarded to widow of sheet metal worker who died of mesothelioma

$1.6 million settlement — suicide after premature hospital discharge

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$1.5 million settlement — construction worker fell off elevated train tracks

$750,000 settlement — defective construction equipment resulted in serious injury to worker


Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.